rifamicina 250 mg/3 ml Sol inj Fr 3 ml IM, Furosemida 40 mg Comp, Cemiplimab 50 mg/ml Sol inj Fr 7 ml IV

ID 10151083 · Portal BASE
Price
Base Price
€73,766 .00
Effective Price
€73,766 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33000000
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
SANOFI - PRODUTOS FARMACÊUTICOS, LDA
NIF 500134960
Company
Dates
Publication
20 Jul 2023
Celebration
26 May 2023
Contracting Entity
Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.
NIF 506362299
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 75 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
20 Jul 2023
Signing Date
26 May 2023
Days Late
55
Rule
A2/A3 late publication: 55 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
73766.0
Threshold
75000.0
Rule
A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06